Ligand · V9S
V9S · 6-[(8E)-8-{2-[4-(benzylcarbamoyl)-1,3-thiazol-2-yl]hydrazinylidene}-5,6,7,8-tetrahydronaphthalen-2-yl]-3-(2-phenylethoxy)pyridine-2-carboxylic acid
V9S, 6-[(8E)-8-{2-[4-(benzylcarbamoyl)-1,3-thiazol-2-yl]hydrazinylidene}-5,6,7,8-tetrahydronaphthalen-2-yl]-3-(2-phenylethoxy)pyridine-2-carboxylic acid (C35 H31 N5 O4 S, 617.7 g/mol), in the MolNFT structures on GenesisL1: bound in 4…
- Component
- V9S
- Formula
- C35 H31 N5 O4 S
- Class
- ligand
- Structures
- 4
- PDB entries
- 2
Binding sites
V9S in 4 structures; the first of them:
- 7JGV · Crystal structure of BCL-xl in complex with compound 1620116, crystal form 2 · V9S A301 · binds ALA93, GLU96, PHE97, TYR101, ARG102, PHE105, SER106, ASP107 and 13 more
- 7JGW · Crystal structure of BCL-XL in complex with COMPOUND 1620116, CRYSTAL FORM 1 · V9S A301 · binds ALA93, GLU96, PHE97, TYR101, ARG102, PHE105, SER106, ASP107 and 14 more
- 7JGV · Crystal structure of BCL-xl in complex with compound 1620116, crystal form 2 · V9S A301 · binds ALA93, PHE97, TYR101, ARG102, PHE105, SER106, ASP107, LEU108 and 11 more
- 7JGW · Crystal structure of BCL-xl in complex with compound 1620116, crystal form 1 · V9S A301 · binds ALA93, PHE97, TYR101, ARG102, PHE105, SER106, ASP107, LEU108 and 11 more
Residues it binds most
ALA 6, PHE 6, ARG 6, LEU 6, SER 6, GLU 6, TYR 6, ASN 6, ASP 6, GLY 6 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.